SLC30A8 polymorphism and BMI complement HLA-A*24 as risk factors for poor graft function in islet allograft recipients. [electronic resource]
Producer: 20181126Description: 1623-1632 p. digitalISSN:- 1432-0428
- Allografts
- Biomarkers -- blood
- Blood Glucose -- drug effects
- Body Mass Index
- Clinical Trials as Topic
- Diabetes Mellitus, Type 1 -- blood
- Female
- HLA-A24 Antigen -- genetics
- Humans
- Hypoglycemic Agents -- therapeutic use
- Insulin -- therapeutic use
- Insulin-Secreting Cells -- immunology
- Islets of Langerhans Transplantation -- adverse effects
- Male
- Middle Aged
- Polymorphism, Genetic
- Recovery of Function
- Retrospective Studies
- Risk Factors
- Treatment Outcome
- Zinc Transporter 8 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.